Products for Research Use Only
RegisterLogin

Guadecitabine sodium

CAT: 0804-HY-15229-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-15229-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Guadecitabine sodium (SGI-110 sodium) is a second-generation DNA methyltransferases (DNMT) inhibitor for research of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) [1].
CAS Number
929904-85-8
Product Name Alternative
SGI-110 sodium; S-110 sodium
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
DNA Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/S-110.html
Purity
99.97
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 25 mg/mL (ultrasonic)
Smiles
O=C1C2=C(N([C@H]3C[C@H](O)[C@@H](COP(O[C@@H]4[C@@H](CO)O[C@@H](N5C=NC(N)=NC5=O)C4)(O[Na])=O)O3)C=N2)NC(N)=N1
Molecular Formula
C18H23N9NaO10P
Molecular Weight
579.39
Precautions
H302, H315, H319, H335
References & Citations
[1]Yoo CB, et al. Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides. Cancer Res. 2007 Jul 1;67 (13) :6400-8.|[2]Chuang JC, et al. S-110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth. Mol Cancer Ther. 2010 May;9 (5) :1443-50.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
DNMT1
Citation 01
BioRxiv. 2024 August 09.|bioRxiv. 2025 February 08.|JID Innov. 2024 Oct 16;5 (2) :100319.|McGill University. 2025.|Research Square Print. January 3rd, 2023.|Cancer Res. 2020 Jul 15;80 (14) :3046-3056.|Epigenomes. 2021 Dec 14;5 (4) :27.|J Exp Clin Cancer Res. 2023 Mar 18;42 (1) :67.|J Transl Med. 2024 Mar 1;22 (1) :223.|Mol Cell. 2022 Oct 20;82 (20) :3901-3918.e7.|Neoplasia. 2020 May 25;22 (7) :274-282.|University of Siena. Department of Medical Biotechnologies. 2021 May.

Related Products

CatalogName
HY-13542Guadecitabine
HY-N15194AInostamycin A (sodium)
HY-166084Docosatetraenoate (sodium)
HY-16366ABriciclib (sodium)
HY-150364AFarabursen (sodium)
HY-107943Tyropanoate (sodium)
HY-W009640AMofebutazone (sodium)
HY-22274-01DMPG (sodium)
HY-17474A-01Parecoxib (Sodium)
HY-148089A-01Eplontersen (sodium)

Alternative Products

CatalogName
471125Guadecitabine sodium
A21257-50Guadecitabine sodium 50mg
A21257-1Guadecitabine sodium 1mg
A21257-25Guadecitabine sodium 25mg
A21257-10Guadecitabine sodium 10mg
A21257-5Guadecitabine sodium 5mg
A21257-100Guadecitabine sodium 100mg
E8205Guadecitabine
MBS387406-01SGI-110 (Guadecitabine)
C12381-100mgGuadecitabine (SGI-110)

Popular Products